Alcidion Group Limited (Alcidion), an ASX-listed company, has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the quality and efficiency of patient care in healthcare organizations, worldwide. Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market.
ASX Code | ALC |
Website | http://www.alcidion.com |
Industry/Sector | Health Care Technology |
Market Cap ($M) | 68 |
ALC Share Price | $0.051 |
Day High | $0.051 |
Day Low | $0.050 |
Last Close | $0.051 |
ALC Share Price Movement | - ( No change ) |
There are no dividends for Alcidion Group Limited (ALC). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
---|---|---|---|---|---|
Alcidion signs $3.4M contract extension with DGT NHS Trust | 6 Mar 2024 8:42AM | $0.051 | $0.051 | $0.051 | fallen by 0% |
Becoming a substantial holder | 4 Mar 2024 8:25PM | $0.047 | $0.051 | $0.051 | risen by 8.51% |
Alcidion H1 FY2024 Results | 28 Feb 2024 8:41AM | $0.045 | $0.051 | $0.051 | risen by 13.33% |
See all ASX announcements from Alcidion Group Limited (ALC) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
---|---|---|---|---|---|---|---|
2024F | C2 | -$0.50 | 55.20% | 0.00 | 0.00 | 0.00% | 0.0% |
2023A | -$3.62 | -$0.30 | 45.00% | 0.00 | 0.00 | 0.00% | 0.0% |
2022A | -$2.28 | -$0.20 | 42.90% | 0.00 | 0.00 | 0.00% | 0.0% |
Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
2022 A | 2023 A | 2024 F | 2022 A | 2023 A | 2024 F | 2022 A | 2023 A | 2024 F | ||
Alcidion Group (ALC) | $67M | 0.4500 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
Pro Medicus (PME) | $10,708M | 0.3647 | 0.2997 | 0.2559 | 176.7931 | 136.0308 | 108.3131 | 0.29% | 0.37% | 0.42% |
Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
---|---|---|---|---|
Company | 0.00 | 0.00 | 0.72 | 0.00 |
Market | 0.50 | 15.20 | 1.13 | 1.13 |
Sector | 0.97 | 36.10 | 2.43 | 3.04 |
Name | Position | Start Date |
---|---|---|
Ms Katrina (Kate) Elizabeth Doyle (Quirke) | Chief Executive Officer, Executive Director, Managing Director | 3 Jul 2018 |
Mr Simon Chamberlain | Non-Executive Director | 1 Jul 2019 |
Ms Victoria Weekes | Non-Executive Director | 1 Sep 2021 |
Mr Daniel Sharp | Non-Executive Director | 1 Sep 2021 |
Ms Rebecca Wilson | Non-Executive Director, Non-Executive Chairman | 31 Jul 2017 |
Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
---|---|---|---|---|---|---|
5 Sep 2023 | WEEKES, Victoria | Buy | Direct Shares | 100,000 | $0.120 | $12,000.000 |
9 May 2023 | SHARP, Daniel | Buy | Direct Shares | 210,000 | $0.096 | $20,230.980 |
5 May 2023 | SHARP, Daniel | Buy | Direct Shares | 590,000 | $0.094 | $55,191.920 |
See all changes in directors' interest & trades for Alcidion Group Limited (ALC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
Name | Position |
---|---|
Melanie Jaye Leydin | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Alcidion Group Limited (ALC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
Holding | Name |
---|---|
134,582,403 (10.61%) | Malcolm Pradhan |
114,116,042 (9%) | Australiansuper Pty Ltd |
75,801,020 (5.98%) | Raymond Howard Blight |
Date | Event |
---|---|
26 February 2025 | Report (Interim) |
22 August 2024 | Report (Annual) |
22 August 2024 | Report (Prelim) |
Alcidion Group Limited's (ALC) current share price is $0.05. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -59.20% below ALC's 12-month high of $0.13 per share. Prices are delayed by at least 20 minutes.
Relative to the previous close share price of $0.05, Alcidion Group Limited's (ALC) current share price of $0.05 constitutes a movement of or 0%. Alcidion Group Limited's (ALC) share price movement is 0% when compared to 7 days ago and is -59.20% below ALC's 52-week high of $0.13.
Alcidion Group Limited's (ALC) 52-week high is $0.13 which was reached on 30 Mar 2023. Relative to this, ALC's current share price of $0.05 constitutes a -$0.07 or -59.20% drop since that high of $0.13 per ALC share.
Alcidion Group Limited's (ALC) 52-week low is $0.05 which was reached on 27 Feb 2024. Relative to this, ALC's current share price of $0.05 constitutes a $0.01 or 13.33% gain since that low of $0.05 per ALC share.
Over the last 12 months, Alcidion Group Limited (ALC) has a daily average trading volume of 1,472,593 ALC shares per day.
Alcidion Group Limited (ALC) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for ALC is a ratio that tells you the percentage of Alcidion Group Limited's (ALC) share price that it pays out in dividends each year.
Alcidion Group Limited (ALC) has a franking level of 0%. Franking represents the tax Alcidion Group Limited (ALC) has already paid on any profit it distributes to shareholders as a dividend.
Alcidion Group Limited (ALC) will release its next Annual Report on 22 August 2024. Alcidion Group Limited's (ALC) last annual report was released on 24 Aug 2023. Click here to view Alcidion Group Limited's (ALC) last annual report.
Alcidion Group Limited (ALC) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Sonic Healthcare Limited (SHL).
The price-to-earnings (P/E) ratio for Alcidion Group Limited (ALC) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Alcidion Group Limited's (ALC) share price to its earnings per ALC share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.